| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-08 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |